BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 29153942)

  • 21. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial.
    Punnen S; Nahar B; Prakash NS; Sjoberg DD; Zappala SM; Parekh DJ
    Eur Urol Focus; 2017 Feb; 3(1):94-99. PubMed ID: 28720374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H; Jung G; Kim JH; Byun SS; Hong SK
    Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Ferro M; Terracciano D; Musi G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Buonerba C; Morelli M; Mistretta FA; Luzzago S; Perdonà S; Del Prete P; Del Giudice F; Busetto GM; Porreca A; Autorino R; Manfredi M; Porpiglia F; Muto M; Loizzo D; Ditonno P; Battaglia M; Lucarelli G
    Urol Int; 2022; 106(1):75-82. PubMed ID: 34167120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
    Briganti A; Joniau S; Gontero P; Abdollah F; Passoni NM; Tombal B; Marchioro G; Kneitz B; Walz J; Frohneberg D; Bangma CH; Graefen M; Tizzani A; Frea B; Karnes RJ; Montorsi F; Van Poppel H; Spahn M
    Eur Urol; 2012 Mar; 61(3):584-92. PubMed ID: 22153925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of metabolic syndrome and prostate cancer.
    Gacci M; Russo GI; De Nunzio C; Sebastianelli A; Salvi M; Vignozzi L; Tubaro A; Morgia G; Serni S
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):146-155. PubMed ID: 28220805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
    Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
    Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment and evaluation of a model for predicting ISUP pathological grade≥2 before radical prostatectomy].
    Wang YF; Zhang YY; Tan SX; Pan P; Wei CG; Shen JK
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(45):3754-3759. PubMed ID: 34856705
    [No Abstract]   [Full Text] [Related]  

  • 31. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.
    Zhang GM; Zhu Y; Dong DH; Han CT; Gu CY; Gu WJ; Qin XJ; Sun LJ; Ye DW
    Asian J Androl; 2015; 17(5):839-44. PubMed ID: 25652638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
    Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
    Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and prostate cancer in Afro-Caribbean men.
    Lefebvre F; Blanchet-Deverly A; Michineau L; Blanchet P; Multigner L; Brureau L
    Prostate; 2022 Feb; 82(3):359-365. PubMed ID: 34905623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.
    Zhang GM; Qin XJ; Zhang HL; Xiao WJ; Zhu Y; Gu CY; Dai B; Shi GH; Ye DW
    Asian J Androl; 2015; 17(2):239-44. PubMed ID: 25475662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
    Porcaro AB; Tafuri A; Sebben M; Corsi P; Pocessali T; Pirozzi M; Amigoni N; Rizzetto R; Mariotto A; Inverardi D; Brunelli M; Iacovelli R; Romano M; Siracusano S; Artibani W
    Urol Int; 2018; 101(1):38-46. PubMed ID: 29975957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
    Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
    BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.